vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Telesat Corp (TSAT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $73.8M, roughly 1.1× Telesat Corp). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -119.8%, a 81.8% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -64.0%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Telesat, formerly Telesat Canada, is a Canadian satellite communications company founded on May 2, 1969. The company is headquartered in Ottawa.

PRCT vs TSAT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$73.8M
TSAT
Higher net margin
PRCT
PRCT
81.8% more per $
PRCT
-38.1%
-119.8%
TSAT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-64.0%
TSAT

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
PRCT
PRCT
TSAT
TSAT
Revenue
$83.1M
$73.8M
Net Profit
$-31.6M
$-88.4M
Gross Margin
64.9%
95.3%
Operating Margin
-4.1%
5.9%
Net Margin
-38.1%
-119.8%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TSAT
TSAT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$83.3M
$73.8M
Q2 25
$79.2M
$77.5M
Q1 25
$69.2M
$152.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
$363.2M
Net Profit
PRCT
PRCT
TSAT
TSAT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
$-88.4M
Q2 25
$-19.6M
$55.1M
Q1 25
$-24.7M
$-52.3M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
$547.4M
Gross Margin
PRCT
PRCT
TSAT
TSAT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
95.3%
Q2 25
65.4%
95.9%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
TSAT
TSAT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
5.9%
Q2 25
-28.0%
16.8%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
PRCT
PRCT
TSAT
TSAT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
-119.8%
Q2 25
-24.7%
71.2%
Q1 25
-35.8%
-34.4%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
150.7%
EPS (diluted)
PRCT
PRCT
TSAT
TSAT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TSAT
TSAT
Cash + ST InvestmentsLiquidity on hand
$245.6M
$352.3M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$1.6B
Total Assets
$487.1M
$5.1B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TSAT
TSAT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
$352.3M
Q2 25
$302.7M
$399.6M
Q1 25
$316.2M
$552.1M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
$1.7B
Total Debt
PRCT
PRCT
TSAT
TSAT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TSAT
TSAT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
$1.6B
Q2 25
$385.8M
$1.7B
Q1 25
$389.2M
$2.5B
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
$2.4B
Total Assets
PRCT
PRCT
TSAT
TSAT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$511.5M
$5.1B
Q2 25
$513.1M
$4.9B
Q1 25
$519.4M
$6.9B
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
$6.3B
Debt / Equity
PRCT
PRCT
TSAT
TSAT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TSAT
TSAT

Segment breakdown not available.

Related Comparisons